Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,074,825
-$499,975 QoQ
Shares Held
40,168
+0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#577
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $469,974,787 across 11 Drug Manufacturers - General names. GILD ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
996,566 | $188,968,844 | |
| 2 | LLY |
ELI LILLY & Co
|
153,860 | $184,544,315 | |
| 3 | ABBV |
AbbVie Inc.
|
113,870 | $28,654,246 | |
| 4 | AMGN |
Amgen Inc
|
74,744 | $27,066,297 | |
| 5 | PFE |
Pfizer Inc
|
785,251 | $18,908,844 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,347 | $5,436,274 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
40,168 | $5,074,825 | |
| 8 | GRFS |
Grifols SA
|
642,946 | $4,552,057 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,074,825 | 40,168 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,574,800 | 40,000 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,584,339 | 37,350 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,235,760 | 38,160 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,317,832 | 38,945 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,211,623 | 37,587 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $8,073,599 | 87,405 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,634,262 | 102,985 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,847,287 | 85,225 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,879,338 | 80,264 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,623,228 | 69,414 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,358,435 | 58,159 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,784,847 | 36,134 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $589,360 | 6,865 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $423,501 | 6,865 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $459,928 | 7,441 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $728,381 | 12,252 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $5,450,397 | 75,064 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,582,202 | 79,917 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,712,901 | 82,964 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,061,950 | 78,322 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,123,093 | 87,935 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,531,210 | 87,533 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,431,008 | 109,579 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,731,091 | 90,036 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||